Identification, classification and labelling, legal status and use restrictions

AuthorClemm, Christan; Löw, Clara; Baron, Yifaat; Moch, Katja; Möller, Martin; Köhler, Andreas R; Gensch, Carl-Otto; Deubzer, Otmar
Pages12-18
RoHS Annex II Dossier, final
Diantimony trioxide (flame retardant)
12
1 IDENTIFICATION, CLASSIFICATION AND LABELLING, LEGAL STATUS AND
USE RESTRICTIONS
Identification
1.1.1 Name, other identifiers, and composition of the substance
The information compiled in the following table on the substance identity of diantimony trioxide
originates from the ECHA information on substances database3 and the European Risk Assessment
Report (EU RAR) on diantimony trioxide from 2008.4
Table
1-1: Substance identity and composition of diantimony trioxide
Chemical name
Diantimony trioxide
EC number 215-175-0
CAS number 1309-64-4
Index number in Annex VI
of the CLP Regulation 051-005-00-X
Molecular formula Sb2O3
Molecular weight 291,49 g/mol
IUPAC name oxostibanyl stibinate, dioxodistiboxane
Synonyms Antimony (III) oxide
Antimony (3+) oxide
Antimony oxide (Sb2O3)
Antimony peroxide
Antimony trioxide
Antimony oxide
Antimony sesquioxide
Antimony white
Flowers of antimony
Senarmontite
Valentinite
Sesquioxide
C.I. Pigment White 11
C.I. 77052
ATO, PATOX
Structural formula
Degree of purity ECHA database of registered substances lists different compositions and
indicates different impurities
The EU RAR indicates the purity for diantimony trioxide at 99.3 to 99.5 % (with
the exception of wetted forms, for which a lower specification limit of 95 % was
given)
Remarks None
Source:
European Chemicals Agency ECHA, Brief Profile: Entry for Diantimony trioxide (2018), https://echa.europa.eu and EU RAR
(2008)
3 ECHA Brief Profile: Entry for Diantimony trioxide; https://echa.europa.eu/de/brief-profile/-/briefprofile/100.013.796,
last viewed 19.04.2018
4 European Union Risk Assessment Report EU RAR (2008): Diantimony trioxide, November 2008;
http://www.echa.europa.eu/documents/10162/553c71a9-5b5c-488b-9666-adc3af5cdf5f, last viewed 19.04.2018

To continue reading

Request your trial

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT